Publications

Finley BL, Benson SM, Marsh GM. 2018. Response to letters regarding “Cosmetic talc as a risk factor for pleural mesothelioma: A weight of evidence evaluation of the epidemiology.” Inhal Toxicol 30(1):1-14; doi: 10.1080/08958378.2018.1438540. PMID: 29464998.

Mihalchik AL, Rogers EN. 2018. Classes of compounds with GI tract toxicity. Chapter 13 in: Gad SC (ed), Toxicology of the Gastrointestinal Tract. CRC Press.

Toxicology Division, Texas Commission on Environmental Quality. 2017. White Paper: TCEQ Guidelines for Systematic Review and Evidence Integration. December 20. Prepared for Texas Commission on Environmental Quality (TCEQ). Available from: https://www.tceq.texas.gov/downloads/toxicology/dsd/position-white-papers/srguidelines.pdf.

Broome C, Cunningham JM, Mullins M, Jiang X, Bylsma L, Fryzek J, Rosenthal A. Incidence of thromboembolic events is increased in a retrospective analysis of a large cold agglutinin disease (CAD) cohort. Presented at the American Society of Hematology, Atlanta, GA, December 2017.

Thompson CM, Wolf, JC, McCoy A, Suh M, Proctor DM, Kirman CR, Haws LC, Harris MA. 2017. Comparison of toxicity and recovery in the duodenum of B6C3F1 mice following treatment with intestinal carcinogens captan, folpet, and hexavalent chromium. Toxicol Pathol 45(8):1091–1101; doi: 10.1177/019262331yy4324. PMID: 29161989.

Wikoff DS, Welsh BT, Henderson R, Brorby G, Britt J, Myers E, Goldberger J, Lieberman HR, O’Brien C, Doepker C. Application of systematic reviews in the evaluation of caffeine safety: Potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Society of Risk Analysis Annual Meeting, Arlington, VA, December 2017.

Sanz F, Pognan F, Steger-Hartmann T, Díaz C, Cases M, Pastor M, Marc P,…, Greene N, et al. 2017. Legacy data sharing to improve drug safety assessment: The eTOX project. Nat Rev Drug Discov 6(12):811-812; doi: 10.1038/nrd.2017.177. PMID: 29026211.

Schaefer HR, Myers, JL. 2017. Guidelines for performing systematic reviews in the development of toxicity factors. Regul Toxicol Pharmacol 91(Dec):124-141; doi: 10.1016/j.yrtph.2017.10.008. PMID: 29080853.

Wheeler MW, Dunson DB, Herring AH. 2017. Bayesian local extremum splines. Biometrika 104(4):939-52; doi: 10.1093/biomet/asx039. PMID: 29422695.

Stephenson CJ, Rossheim ME, Frankenfeld CL, Boncy J, Okech BO, von Fricken ME. 2017. Cross-sectional analysis of the association between bedtime and malaria exposure in the Ouest and Sud-Est Departments of Haiti. Acta Tropica 176(Dec):188–19; doi: 10.1016/j.actatropica.2017.08.011. PMID: 28818627.

Bare JL, Abramson MM, Barlow CA, Scott PK. Use of air dispersion modeling to estimate historical community exposure from manufacturers of asbestos-containing products. Abstract P.96, Society for Risk Analysis (SRA) Annual Meeting, Arlington, VA, December 2017.

Jensen IS, Wu E, Sacks N, Cyr P, Chung K. Budget impact analysis of CPX-351 in the treatment of patients with treatment-related acute myeloid leukemia (tAML) or AML with myelodysplasia-related changes (MRC) from a US payer perspective. Abstract 5615, 59th American Society of Hematology (ASH) Annual Meeting. Blood 130(Sup 1):5615; 10.1182/blood.V130.Suppl_1.5615.5615. Atlanta, GA, December 2017.

Lansita J, Mease KM, Qiu H, Yednock T, Sankaranarayanan S, Kramer S. 2017. Nonclinical development of ANX005: A humanized anti-Clq antibody for treatment of autoimmune and neurodegenerative diseases. Int J Toxicol 36(6)449-462; doi: 10.1177/1091581817740873. PMID: 29202623.

Schaefer HR, Ethridge S, Myers, JL. 2017. Development Support Document for Ethylene Dibromide. CAS Registry No.: 106-93-4. Final. November 29. Prepared for Texas Commission on Environmental Quality (TCEQ). Available from: https://www.tceq.texas.gov/downloads/toxicology/dsd/final/edb.pdf.

Williams A, Grulke C, Edwards J, McEachran A, Mansouri K, Baker N, Patlewicz G, Shah I, et al. 2017. The CompTox Chemistry Dashboard–A community data resource for environmental chemistry. J Cheminform 9(1):61; doi: 10.1186/s13321-017-0247-6. PMID: 29185060.

Liu J, Patlewicz G, Williams A, Thomas RS, Shah I. 2017. Predicting organ toxicity using in vitro bioactivity data and chemical structure. Chem Res Toxicol 30(11):2046-2059; doi: 10.1021/acs.chemrestox.7b00084. PMID: 28768096.

Butler L, Guzzie-Peck P, Hartke J, Bogdanffy M, Will Y, Diaz D, Mortimer-Cassen E,.., Greene N, et al. Revised draft EMA guidance on early clinical trials: Potential impacts and industry response. Abstract P204, American College of Toxicology 38th Annual Meeting. Int J Toxicol 37(1):75-76; doi: 10.1177/10915818177494. Palm Springs, CA, November 2017.

Thompson CM, Suh M, Proctor DM, Haws LC, Harris MA. 2017. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents. Mutat Res 823(Nov):45-57; doi: 10.1016/j.mrgentox.2017.08.004. PMID: 28985946.

Wheeler MW, Bailer AJ, Cole T, Park RM, Shao K. 2017. Bayesian quantile impairment threshold benchmark dose estimation for continuous endpoints. Risk Anal 37(11):2107-18; doi: 10.1111/risa.12762. PMID: 28555874.

Vincent MJ, Parker A, Maier A. 2017. Cleaning and asthma: A systematic review and approach for effective safety assessment. Regul Toxicol Pharmacol 90(Nov):231–243; doi: 10.1016/j.yrtph.2017.09.013. PMID: 28918194.